絞り込み

18402

広告

「"Stahel R "[Author]」の検索結果

140件中 1件~20件表示    検索結果をPubMedで見る PubMedで見る

Clinical Case Presentation and Discussion During ESO-ESMO Masterclass: a 10-Year Interactive Educational Experience.

Changing the education paradigm in oncology: ESO masterclass, 17 years of continuous success.

ESO-ESMO Masterclass in Clinical Oncology: Analysis and Evaluation of the Learning Self-Assessment Test.

Stereotactic Body Radiation Therapy (SBRT) as Salvage Therapy for Oligorecurrent Pleural Mesothelioma After Multi-Modality Therapy.

Underweight and weight loss are predictors of poor outcome in patients with brain metastasis.

Impact of delayed and prolonged fixation on the evaluation of immunohistochemical staining on lung carcinoma resection specimen.

miR-625-3p and lncRNA GAS5 in Liquid Biopsies for Predicting the Outcome of Malignant Pleural Mesothelioma Patients Treated with Neo-Adjuvant Chemotherapy and Surgery.

A retrospective cohort study of PD-L1 prevalence, molecular associations and clinical outcomes in patients with NSCLC: Results from the European Thoracic Oncology Platform (ETOP) Lungscape Project.

Position of a panel of international lung cancer experts on the approval decision for use of durvalumab in stage III Non-Small Cell Lung Cancer (NSCLC) by the Committee for Medicinal Products for Human Use (CHMP).

Trastuzumab Emtansine (T-DM1) in Patients with Previously Treated HER2-Overexpressing Metastatic Non-Small Cell Lung Cancer: Efficacy, Safety and Biomarkers.

Diagnostic value of F-fluordesoxyglucose positron emission tomography for patients with brain metastasis from unknown primary site.

Live-Cell Mesothelioma Biobank to Explore Mechanisms of Tumor Progression.

Evaluation of NGS and RT-PCR methods for ALK rearrangement in European NSCLC patients: Results from the ETOP Lungscape Project.

PD-1 blockade in advanced NSCLC: A focus on pembrolizumab.

Propensity matched comparison of extrapleural pneumonectomy and pleurectomy/decortication for mesothelioma patients†.

A novel BRCA1-associated protein-1 isoform affects response of mesothelioma cells to drugs impairing BRCA1-mediated DNA repair.

Career opportunities and benefits for young oncologists in the European Society for Medical Oncology (ESMO).

Prognostic and predictive value of loss of nuclear RAD51 immunoreactivity in resected non-small cell lung cancer patients.

Propensity matched comparison of extrapleural pneumonectomy and pleurectomy/decortication for mesothelioma patients†.

Toxicity of concurrent stereotactic radiotherapy and targeted therapy or immunotherapy: A systematic review.

  1. 1
  2. 2
  3. 3
  4. 4
  5. 5
  6. 6
  7. 7
Sort by
※並べ替えは表示に時間がかかります